RecruitingRespiratory Health
Air Purifier Use and Respiratory Health in COPD Patients
Eligible age
50–80 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This randomized, double-blind, parallel-controlled trial aims to evaluate the effects of an indoor air purifier intervention on respiratory health in patients with Chronic Obstructive Pulmonary Disease (COPD).
Sponsor: Fudan University
You may qualify if…
- ✓ Age between 50 and 80 years old
- ✓ Physician diagnosis of COPD
- ✓ Living in Shanghai during the intervention period
- ✓ Subjects who have no plans to change homes during the intervention period
- ✓ Non-smokers and former smokers
You may not qualify if…
- ✕ Subjects living in a location other than home
- ✕ Subjects with a history of alcohol abuse
- ✕ Subjects with other chronic lung diseases, such as active tuberculosis, pulmonary fibrosis, cystic fibrosis, or alpha-1 antitrypsin deficiency
- ✕ Subjects with a history of thoracic surgery
- ✕ Subjects with a history of malignant tumors, such as lung cancer, liver cancer, or gastric cancer
- ✕ Subjects with diagnosed chronic hepatic or renal insufficiency, such as liver cirrhosis, chronic viral hepatitis, or autoimmune liver disease
- ✕ Subjects with acute myocardial infarction or unstable arrhythmia diagnosed within the past 6 weeks
- ✕ Subjects currently participating in other interventional studies
Source: ClinicalTrials.gov · NCT07505602 · last updated 2026-06-09